TNF and inflammatory bowel disease: For a long time, proinflammatory factors such as TNF‐α and IL‐6 in IBD patients have aroused people's attention, and monoclonal antibodies or small‐molecule drugs targeting specific cytokines or their receptors have been used to treat IBD.